SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lisa G. Rider, Carol B. Lindsley, Frederick W. Miller, Textbook of Pediatric Rheumatology, 2016,

    CrossRef

  2. 2
    Lauren M. Pachman, Neuromuscular Disorders of Infancy, Childhood, and Adolescence, 2015,

    CrossRef

  3. 3
    E. M. Moran, F. L. Mastaglia, Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications, Clinical & Experimental Immunology, 2014, 178, 3
  4. 4
    Jeffrey A Dvergsten, Ann M Reed, Progress and prognosis in juvenile dermatomyositis, International Journal of Clinical Rheumatology, 2014, 9, 6, 567

    CrossRef

  5. 5
    Masaya Yokota, Kotaro Suzuki, Koji Tokoyoda, Kazuyuki Meguro, Junichi Hosokawa, Shigeru Tanaka, Kei Ikeda, Takashi Mikata, Toshinori Nakayama, Hitoshi Kohsaka, Hiroshi Nakajima, Roles of mast cells in the pathogenesis of inflammatory myopathy, Arthritis Research & Therapy, 2014, 16, 2, R72

    CrossRef

  6. 6
    F. M. Moret, T. R. D. J. Radstake, J. A. G. van Roon, Targeting Th2-typified immune responses to prevent immunopathology in rheumatic diseases: belittled therapeutic strategies?, Annals of the Rheumatic Diseases, 2014, 73, 3, 477

    CrossRef

  7. 7
    Lisa G. Rider, James D. Katz, Olcay Y. Jones, Developments in the Classification and Treatment of the Juvenile Idiopathic Inflammatory Myopathies, Rheumatic Disease Clinics of North America, 2013, 39, 4, 877

    CrossRef

  8. 8
    Jeremy Di Domizio, Wei Cao, Fueling autoimmunity: type I interferon in autoimmune diseases, Expert Review of Clinical Immunology, 2013, 9, 3, 201

    CrossRef

  9. 9
    B. Stuhlmüller, E. Feist, T. Häupl, G.-R. Burmester, N. Pipitone, Neues zur Pathogenese der Myositiden, Zeitschrift für Rheumatologie, 2013, 72, 3, 209

    CrossRef

  10. You have free access to this content10
    R. Goldbach-Mansky, Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1, Clinical & Experimental Immunology, 2012, 167, 3
  11. 11
    Min Wang, Hehuang Xie, Sheela Shrestha, Simone Sredni, Gabrielle A. Morgan, Lauren M. Pachman, Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsy samples from patients with untreated juvenile dermatomyositis suggest self-renewal capacity, Arthritis & Rheumatism, 2012, 64, 10
  12. 12
    Lisa C. Zaba, David F. Fiorentino, Skin disease in dermatomyositis, Current Opinion in Rheumatology, 2012, 24, 6, 597

    CrossRef

  13. 13
    Angela B. Robinson, Ann M. Reed, Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis, Nature Reviews Rheumatology, 2011, 7, 11, 664

    CrossRef

  14. 14
    E. Futata, M. Azor, J. Dos Santos, C. Maruta, M. Sotto, F. Guedes, E. Rivitti, A. Duarte, M. Sato, Impaired IFN-α secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria, British Journal of Dermatology, 2011, 164, 6
  15. 15
    Yvonne E. Chiu, Dominic O. Co, Juvenile Dermatomyositis: Immunopathogenesis, Role of Myositis-Specific Autoantibodies, and Review of Rituximab Use, Pediatric Dermatology, 2011, 28, 4
  16. 16
    Lily Kao, Lorinda Chung, David F. Fiorentino, Pathogenesis of Dermatomyositis: Role of Cytokines and Interferon, Current Rheumatology Reports, 2011, 13, 3, 225

    CrossRef

  17. 17
    Emily C Baechler, Hatice Bilgic, Ann M Reed, Type I interferon pathway in adult and juvenile dermatomyositis, Arthritis Research & Therapy, 2011, 13, 6, 249

    CrossRef

  18. 18
    Lisa G. Rider, Frederick W. Miller, Mast cells and type I interferon responses in the skin of patients with juvenile dermatomyositis: Are current therapies just scratching the surface?, Arthritis & Rheumatism, 2010, 62, 9